Keyphrases
Coronavirus Vaccine
100%
Eosinophils
50%
Immunization
100%
Infectious Virus
25%
Interleukin-13 (IL-13)
25%
Interleukin-5 (IL-5)
25%
Live Virus
100%
Lung
50%
Lung Immunopathology
100%
Lung Pathology
50%
MERS-CoV Infection
25%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
100%
Neutralizing Antibodies
25%
SARS-CoV Infection
25%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
50%
Virus
25%
Virus Challenge
25%
Medicine and Dentistry
Adjuvant
20%
Cytokine
20%
Eosinophil
40%
Immunopathology
100%
Infection
40%
Interleukin 13
20%
Middle East Respiratory Syndrome Coronavirus
100%
Neutralizing Antibody
20%
Pulmonary Pathology
40%
SARS Coronavirus
60%
Virus Infectivity
20%
Immunology and Microbiology
Adjuvant
12%
Cytokine
12%
Eosinophil
12%
Eosinophil Granulocyte
12%
Immunopathology
100%
Interleukin 13
12%
Middle East Respiratory Syndrome Coronavirus
100%
Mouse
37%
Neutralizing Antibody
12%
SARS Coronavirus
37%
Vaccine Efficacy
100%
Virus Infectivity
12%
Pharmacology, Toxicology and Pharmaceutical Science
Adjuvant
20%
Cytokine
20%
Immunopathology
100%
Infection
40%
Interleukin 13
20%
Middle East Respiratory Syndrome Coronavirus
100%
Mouse
60%
Neutralizing Antibody
20%
SARS Coronavirus
60%
Virus Infectivity
20%